Urinary Tract Infection

Infectious Disease·MeSH: Urinary Tract Infections

18 drugs in development·12 companies·2 clinical trials

Drug Pipeline by Phase

Approved(10)

Drug	Company
amoxicillin	Aptinyx Inc. (APTX)
amoxicillin	SUNSET ISLAND GROUP (SUN)
Cefaclor Dispersible Tablets	CHINA PHARMA HOLDINGS, INC. (CPHI)
Cefalexin Capsules	CHINA PHARMA HOLDINGS, INC. (CPHI)
cefepime	Seagen Inc. (SGEN)
cefepime	Atara Biotherapeutics, Inc. (ATRA)
fluconazole	ANI PHARMACEUTICALS INC (ANIP)
orlynvah	Iterum Therapeutics plc (ITRM)
zemdri	Achaogen, Inc. (AKAO)
zerbaxa	Curative Biotechnology Inc (CUBT)

Phase 3(4)

Phase 1(2)

Drug	Company
etx0282cpdp	Entasis Therapeutics Holdings Inc. (ETTX)
tbp-pi-hbr	Spero Therapeutics, Inc. (SPRO)

Preclinical(1)

Drug	Company
nrx-101	NRX Pharmaceuticals Inc. (NRXP)

BLA Filed(1)

Drug	Company
plazomicin	Achaogen, Inc. (AKAO)

BioSniper tracks 18 drugs in development for Urinary Tract Infection across 12 companies.

There are 2 clinical trials targeting Urinary Tract Infection tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.